Increments in serum cytokine and nitric oxide levels in mice injected with Bothrops asper and Bothrops jararaca snake venoms

被引:124
作者
Petricevich, VL
Teixeria, CFP
Tambourgi, DV
Gutiérrez, JM
机构
[1] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica
[2] Pharmacol Inst Butantan, BR-05504900 Sao Paulo, Brazil
[3] Labs Immunochem, BR-05504900 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
D O I
10.1016/S0041-0101(99)00227-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Changes in serum levels of several cytokines and nitric oxide were studied in BALB/c mice injected intraperitoneally with one median lethal dose (LD50) of the venoms of Bothrops asper and Bothrops jararaca, two of the medically most important poisonous snakes of Latin America. Despite differences observed in the time-course of cytokine increments and in serum cytokine levels, both venoms induced prominent elevations of TNF-alpha, IL-1, IL-6, IL-10 and IFN-gamma. There was an early increase in TNF-alpha and IL-1, followed by a more pronounced increment by 18 h. IL-6 levels peaked-between 4 and 6 h, and this cytokine probably modulates the secretion of TNF-alpha and IL-1 and the synthesis of acute-phase proteins, Both venoms induced an early increment in serum IL-10, whereas IFN-gamma levels reached higher values in mice injected with B. jararaca venom than in those receiving B. asper venom, Serum nitric oxide concentration increased in mice injected with both venoms rapidly after envenomation, remaining elevated for 24 h. It is concluded that a complex pattern of cytokine and nitric oxide synthesis and secretion occurs in severe experimental envenomation by B, asper and B. jararaca venoms. Furthermore, it is suggested that some of these mediators, particularly TNF-alpha, IL-1 and nitric oxide, might play a relevant role in the pathophysiology of systemic alterations induced by these venoms. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1253 / 1266
页数:14
相关论文
共 51 条
[11]  
CARDOSO JLC, 1993, Q J MED, V86, P315
[12]  
CASTELL JV, 1989, ANN NY ACAD SCI, V557, P87
[13]  
DASILVA AMM, 1996, EUR J IMMUNOL, V26, P2000
[14]   PLASMA TUMOR NECROSIS FACTOR AND MORTALITY IN CRITICALLY ILL SEPTIC PATIENTS [J].
DEBETS, JMH ;
KAMPMEIJER, R ;
VANDERLINDEN, MPMH ;
BUURMAN, WA ;
VANDERLINDEN, CJ .
CRITICAL CARE MEDICINE, 1989, 17 (06) :489-494
[15]   HIGH-LEVELS OF INTERLEUKIN-10 DURING THE INITIAL PHASE OF FULMINANT MENINGOCOCCAL SEPTIC SHOCK [J].
DERKX, B ;
MARCHANT, A ;
GOLDMAN, M ;
BIJLMER, R ;
VANDEVENTER, S .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (01) :229-232
[16]   THE PROINFLAMMATORY CYTOKINES INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR AND TREATMENT OF THE SEPTIC SHOCK SYNDROME [J].
DINARELLO, CA .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (06) :1177-1184
[17]  
DING AH, 1988, J IMMUNOL, V141, P2407
[18]  
Endo S, 1992, Mediators Inflamm, V1, P45, DOI 10.1155/S0962935192000097
[19]  
FIORENTINO DF, 1991, J IMMUNOL, V147, P3815
[20]  
GUTIERREZ J M, 1989, Memorias do Instituto Butantan (Sao Paulo), V51, P211